Navigation Links
PHC Announces 19.2% Increase in Fiscal 2011 First Quarter Revenues
Date:11/10/2010

PEABODY, Mass., Nov. 10, 2010 /PRNewswire-FirstCall/ -- PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), a leading provider of inpatient and outpatient behavioral health services, today reported financial results for the Company's 2011 first fiscal quarter ended September 30, 2010.

First Fiscal Quarter of 2011 Highlights

  • For the first fiscal quarter ended September 30, 2010, net patient care revenues increased 21% to $14.2 million from $11.8 million for the same period in 2009.
  • Income from continuing operations increased 247% to $1.2 million from $356,000 for the same period in 2009.
  • Net income applicable to common shareholders increased 204% to $679,000 from net income of $224,000 for the same period in 2009.
  • The Company's Board of Directors authorized the repurchase of up to one million shares of its Class A common stock for a one-year period commencing July 1, 2010. In the fiscal 2011 first quarter, the Company repurchased approximately 100,000 shares at an average price of approximately $1.11 per share.
  • The Company obtained Centers for Medicare and Medicaid Services (CMS) approval for the Seven Hills Behavioral Institute facility, located in Henderson, Nevada, which enables it to immediately accept patients enrolled in the Medicare program.

  • Fiscal First Quarter of 2011 Financial ResultsTotal net revenues from continuing operations for the three months ended September 30, 2010 increased 19.2% to $15.1 million compared to $12.6 million for the three months ended September 30, 2009. Net patient care revenues increased 21.0% to $14.2 million for the three months ended September 30, 2010 from $11.8 million for the three months ended September 30, 2009. This increase in revenue is due primarily to increased census at Seven Hills Hospital in Las Vegas, a retroactive increase from a service contract at Har
    '/>"/>

    SOURCE PHC, Inc., d/b/a Pioneer Behavioral Health
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
    8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
    9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
    10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
    11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
    (Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
    (Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
    Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
    ... ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) ... offering of 21,250,000 shares of its common stock and warrants ... of approximately $17.0 million.  The securities sold in the offering ... a warrant to purchase 0.5 of a share at a ...
    ... 16, 2011 The federal government,s tracking system for ... to account for a new procurement policy implemented last ... higher number of power wheelchairs provided than were actually ... and manufacturers report declines of 30 percent or more ...
    Cached Medicine Technology:ADVENTRX Announces Closing of Public Offering 2ADVENTRX Announces Closing of Public Offering 3American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 3American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 4
    (Date:7/9/2014)... 2014 For the first time, researchers have access ... in Canada uses health care. A new study, called ... demonstrate the unique challenges faced by urban Aboriginal people ... Hospital. , The findings, published today in ... Nations individuals and the general population. , Researchers interviewed ...
    (Date:7/9/2014)... an innovative tool that captures heretofore hidden ways that ... a protein that makes breast cancer cells more likely ... trigger cancer,s spread in part by blocking two other ... that suggests these two disease processes could have unexpected ... July 10 issue of Nature , points to ...
    (Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
    (Date:7/9/2014)... (July 8, 2014) Researchers from Montefiore Medical ... Medicine of Yeshiva University will present new findings ... July 12 July 17 in Copenhagen, Denmark. Data ... could prompt transition from cognitive normality to mild cognitive ... Einstein Aging Study , established in 1980 to ...
    (Date:7/9/2014)... one of the most important organs in the human ... our food properly this is its synthesis function ... organism this is its detoxification function. Lack of ... all damage the liver. The resulting diseased cells can ... life-threatening liver failure. According to the German Liver Foundation, ...
    Breaking Medicine News(10 mins):Health News:Urban Aboriginal people face unique health challenges 2Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3
    ... influenced by advertisements that show horrific consequences of drink-driving ... report . ,The UK Department of ... drink-driving can influence young men not to sit behind ... show that a minimum penalty of a one-year driving ...
    ... David Beckham has admitted that he is a big softie who ... recently moved to the US after joining LA Galaxy, said that ... while he is watching an upsetting scene in the film. ... we'll be watching a film that's not even upsetting and Victoria ...
    ... study has suggested that teens indulgence in non-suicidal ... suspected. ,Non-suicidal self-injury is the deliberate, ... intent. ,The findings are important because ... adolescents in the general population than previously thought, ...
    ... to gain approval from the Food and Drug Administration (FDA), ... Wilson Guthrie, a 61-year-old man from Kansas, suffering from ... home, with that experimental heart-assist device that keeps his heart ... the cardiothoracic ICU has had, and that a lot of ...
    ... last year in Sierra Leone's capital Freetown last year has ... ,A senior health worker attributed the fall in rabies cases ... Doctors at the main referral Connaught Hospital are worried about ... ,The hospital has had to rely heavily on ...
    ... who are not graduates of recognised foreign medical schools, ... to practise in Singapore starting next year, the ... from countries like the Philippines, India and Myanmar, have ... Medical Council has allowed institutions to hire them since ...
    Cached Medicine News:Health News:Drink-drivers Not Influenced by Ads Unless It Affects Them Personally 2Health News:Self-harming Among Teens More Common Than Thought 2Health News:Self-harming Among Teens More Common Than Thought 3Health News:US Patient Implanted With HeartMate II, Leaves ICU 2
    Peribulbar Needle, 25 g. Atkinson style bevel. Overall length 31 mm. 5/box....
    Micro Blade tip 6900 style, straight. Dimensions: 15.2 mm x 2.5 mm x 6.2 mm....
    Needle Knife, straight, full handle, non-reflective, 0.74 mm width....
    Full Handle Laseredge Slit Blade Knife, 3.2 mm angled bevel up. Blade tip dimension: 14.4 mm x 3.2 mm x 3.7 mm....
    Medicine Products: